PMID: 6538257Jan 1, 1984Paper

Cisplatinum-induced renal salt wasting

Medical and Pediatric Oncology
J KurtzbergT R Kinney

Abstract

We report two patients who developed high urinary excretion of sodium chloride after receiving cisplatinum. One patient became symptomatically hyponatremic during intravenous administration of hypotonic fluid. The second patient developed orthostatic hypotension. Urine sodium and chloride concentrations exceeded 130 mmol/liter despite hyponatremia or volume depletion. There was no evidence of adrenal cortical impairment and no improvement with fludrocortisone. We propose that cisplatinum may inhibit solute transport by the thick ascending limb of Henle, causing clinically significant, previously unreported toxicity in patients receiving chronic cisplatinum antitumor therapy.

References

Jun 1, 1979·Annals of Internal Medicine·R L Schilsky, T Anderson
Dec 1, 1979·Kidney International·J W RoweG L Robertson
Apr 1, 1980·Clinical Pharmacology and Therapeutics·B R JonesM M Reidenberg

❮ Previous
Next ❯

Citations

Jan 1, 1986·Cancer Chemotherapy and Pharmacology·M P GorenM E Horowitz
Sep 1, 1996·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·T Berghmans
Apr 29, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·X PivotG Milano
Jul 14, 2010·Southern Medical Journal·Tamim HamdiAshok Patel
Nov 10, 2011·Toxins·Ronald P MillerWilliam Brian Reeves
Dec 12, 2003·Clinical Lung Cancer·Akila V IyerAnthony S Arcenas
May 7, 1998·Endocrine Reviews·S C YeungR F Gagel
Jan 1, 1987·Pediatric Hematology and Oncology·G VassalJ Lemerle
Jan 1, 1988·Pediatric Hematology and Oncology·M S KibirigeG M Addison
Jan 1, 1995·Acta Oncologica·A el WeshiG Catimel
Sep 19, 2018·Esophagus : Official Journal of the Japan Esophageal Society·Ayako ShimadaYuko Kitagawa
Aug 2, 2002·American Journal of Clinical Oncology·Lequn CaoDavid Sumoza
Oct 30, 2020·European Endocrinology·Aishwarya KrishnamurthyDeep Dutta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

Clinical Pharmacology and Therapeutics
D C BraterS Strowig
Journal of Cardiovascular Pharmacology
G Giebisch, G Klein-Robbenhaar
© 2021 Meta ULC. All rights reserved